Monica Bertagnolli: NIH is seeking feedback from the biomedical research community

Monica Bertagnolli shared a post by The National Institutes of Health, on LinkedIn, adding:

”NIH is dedicated to improving the postdoctoral experience to retain and attract our nation’s brightest scientific minds and remain globally competitive. To re-envision NIH’s postdoctoral experience, we are seeking feedback from the biomedical research community. Responses are due by October 23, 2024.”

Quoting The National Institutes of Health’s post:

”NIH is taking steps to re-envision the postdoctoral training experience, but the feedback of the biomedical research community is a crucial part of this process.

Among the actions under consideration are:

• Limiting the amount of time a postdoctoral scholar can be supported by NIH funds to five years to speed transition into research careers.
• Shorten the eligibility window and refocus review criteria for a key mentored career development award (K99/R00) to facilitate more rapid transition of postdoctoral scholars.
• Enhancing training and professional development for postdoctoral scholars and their mentors.

Share your feedback by October 23, 2024.”

Source: Monica Bertagnolli/LinkedIn and The National Institutes of Health/LinkedIn

Monica Bertagnolli is the Director of the National Institute of Health (NIH), USA. She is the President of Alliance for Clinical Trials In Oncology Foundation. She previously served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute. Dr. Bertagnolli is the Founding Chair of the minimal Common Oncology Data Elements (mCODE) executive committee and has held multiple positions nationally, including being Past President and Chair of the Board of Directors of the American Society of Clinical Oncology. In 2021, she was elected to the National Academy of Medicine, having previously served on the National Academies National Cancer Policy Forum.